D
The startup develops boron neutron capture therapy that utilizes boron drugs to target cancer cells, allowing for neutron irradiation without surgical intervention. This method minimizes damage to healthy tissue while effectively destroying cancer cells with just one or two treatments.
Seoul, South Korea
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops boron neutron capture therapy that utilizes boron drugs to target cancer cells, allowing for neutron irradiation without surgical intervention. This method minimizes damage to healthy tissue while effectively destroying cancer cells with just one or two treatments.